Nomura Holdings’s NextCure NXTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,326
Closed -$148K 1628
2022
Q3
$148K Hold
4,326
﹤0.01% 1275
2022
Q2
$236K Hold
4,326
﹤0.01% 1256
2022
Q1
$258K Hold
4,326
﹤0.01% 1489
2021
Q4
$313K Sell
4,326
-4,326
-50% -$362K ﹤0.01% 1666
2021
Q3
$785K Hold
8,652
﹤0.01% 1212
2021
Q2
$833K Buy
8,652
+2,100
+32% +$215K ﹤0.01% 1140
2021
Q1
$797K Buy
6,552
+152
+2% +$22K ﹤0.01% 1182
2020
Q4
$840K Buy
+6,400
New +$827K ﹤0.01% 1094

Other funds holding NXTC

Nomura Holdings's NXTC Position: Q4 2022 in Review

Nomura Holdings sold out of NextCure (NXTC) in Q4 2022, closing a stake of 4,326 shares — an estimated $148K sold.

Nomura Holdings first reported a position in NXTC in Q4 2020 and held it in 8 quarters. The position peaked at $840K in Q4 2020. 45 funds tracked by Wall St. Rank hold NXTC as of Q4 2022.

  • Nomura Holdings reported no remaining NextCure position as of Q4 2022 after selling out during the quarter.
  • Nomura Holdings sold 4,326 NextCure shares in Q4 2022, an estimated $148K.
  • Nomura Holdings first reported a position in NextCure in Q4 2020 and held it in 8 quarters.
  • Nomura Holdings's NextCure position peaked at $840K in Q4 2020.
  • 45 funds tracked by Wall St. Rank held NextCure as of Q4 2022.

Based on Nomura Holdings's 13F filing for Q4 2022, filed 14 Feb 2023.